Snakebite envenoming kills and maims hundreds of thousands of people every year,
especially in the rural settings of tropical regions. Envenomings are still treated with animal …

Snakebite envenoming is a significant global health challenge, and for over a century,
traditional plasma-derived antivenoms from hyperimmunized animals have been the primary …

Despite the considerable global impact of snakebite envenoming, available treatments
remain suboptimal. Here, we report the discovery of a broadly-neutralizing human …

Oligoclonal mixtures of broadly-neutralizing antibodies can neutralize complex compositions
of similar and dissimilar antigens, making them versatile tools for the treatment of eg …

Alternative recombinant sources of antivenoms have been successfully generated. The
application of such strategies requires the characterization of the venoms for the …

Broadly‐neutralizing monoclonal antibodies are becoming increasingly important tools for
treating infectious diseases and animal envenomings. However, designing and developing …

Abstract Single‐domain antibodies (sdAbs), such as VHHs, are increasingly being
developed for gastrointestinal (GI) applications against pathogens to strengthen gut health …

Recently, there has been a major push toward the development of next-generation
treatments against snakebite envenoming. However, unlike current antivenoms that rely on …

Abstract Single-domain antibodies (sdAbs), such as VHHs, are increasingly being
developed for gastrointestinal (GI) applications against pathogens to strengthen gut health …

Snakebite envenoming remains a significant global health challenge, impacting millions of
people annually, particularly in regions with limited access to medical care. The primary …